Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater increase » year increase (Expand Search)
linear decrease » linear increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater increase » year increase (Expand Search)
linear decrease » linear increase (Expand Search)
-
2601
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2602
-
2603
-
2604
-
2605
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2606
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2607
-
2608
-
2609
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2610
-
2611
-
2612
-
2613
-
2614
-
2615
-
2616
-
2617
Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.
Published 2025Subjects: -
2618
-
2619
-
2620
Characteristics and outcomes from clams with MarBTN and control healthy clams.
Published 2025Subjects: